Hybrid Ablation of Nonparoxysmal Atrial Fibrillation: The Convergent and Totally Thoracoscopic Approaches.

Rev Cardiovasc Med

Department of Cardiothoracic Surgery, Saint Helena Hospital, Saint Helena, CA 94574, USA.

Published: October 2022

Nonparoxysmal atrial fibrillation continues to challenge electrophysiologist and surgeons alike. Stand-alone endocardial catheter ablation has resulted in less than satisfying results, and while the on-pump Cox-Maze surgery has excellent results, the invasiveness has limited its adoption amongst both referring providers and surgeons. The CONVERGE IDE trial has shed new light on this once dim problem. EPs and Surgeons are now working together in a Hybrid Team Ablation Approach to provide a combined ablation strategy that has improved patient outcomes and rekindled the collaboration necessary to better patient outcomes. We herein summarize the current Hybrid Team Ablation Approaches (CONVERGE and Totally Thoracoscopic) with nonparoxysmal atrial fibrillation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267342PMC
http://dx.doi.org/10.31083/j.rcm2310338DOI Listing

Publication Analysis

Top Keywords

nonparoxysmal atrial
12
atrial fibrillation
12
totally thoracoscopic
8
hybrid team
8
team ablation
8
patient outcomes
8
hybrid ablation
4
ablation nonparoxysmal
4
fibrillation convergent
4
convergent totally
4

Similar Publications

Although sodium-glucose cotransporter-2 inhibitors (SGLT2i) are known to reduce the incidence of atrial fibrillation (AF) and AF-related adverse events, evidence on their prognostic effect in patients undergoing catheter ablation (CA) for AF is limited. In a single-center, 614 patients (mean age 58.1±9.

View Article and Find Full Text PDF

Background: A novel focal lattice-tip catheter allowing the delivery of either pulsed field (PF) or radiofrequency (RF) energy has recently received regulatory approval. The technology features a proprietary 3-dimensional electroanatomic mapping system.

Objective: We describe the first real-world and multicenter experience.

View Article and Find Full Text PDF

Background: Atrial fibrillation (AF) is a recognized risk factor for mortality after transcatheter aortic valve replacement for severe aortic stenosis, but the impact of different types of AF on clinical outcomes remains unclear.

Methods: This retrospective study included 982 patients divided into 3 groups: no AF, paroxysmal AF, and nonparoxysmal AF (persistent or permanent). Clinical outcomes were analyzed using inverse probability weighting and multivariate models.

View Article and Find Full Text PDF

Background: The clinical outcomes of adjunctive posterior wall isolation (PWI) beyond pulmonary vein isolation (PVI) for non-paroxysmal atrial fibrillation (AF) remain unclear. This meta-analysis was conducted to evaluate the role of PWI in non-paroxysmal AF by pooled analysis of most updated randomized controlled trials (RCTs).

Methods: A literature search in PubMed, Embase, and the Cochrane Library was performed to identify RCTs comparing the outcomes of PVI with and without PWI in non-paroxysmal AF patients.

View Article and Find Full Text PDF

Introduction: Pulmonary vein isolation (PVI) by cryoballoon ablation (CBA) is considered an effective primary strategy for early persistent atrial fibrillation (AF). However, data regarding CBA for long-standing persistent AF (PeAF) are limited. We evaluated the efficacy and safety of CBA for long-standing PeAF compared to PeAF.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!